External beam irradiation of prostate cancer. Conformal treatment techniques and outcomes for the 1990

Background. This paper presents the results of external beam treatment of prostate cancer. Long term results are represented by the U.S. national averages from the Patterns of Care study. The modern innovations of three‐dimensional‐assisted conformal treatment are also shown to demonstrate the technologic progress in external beam treatment, the effect of pretreatment prostate specific antigen (PSA), the inaccuracy of clinical end points used for 30 years, and the new early outcome standards for the 1990s.

[1]  T. Schultheiss,et al.  Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate. , 1995, International journal of radiation oncology, biology, physics.

[2]  A. Zietman,et al.  Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome. , 1994, The Journal of urology.

[3]  T. Stamey,et al.  The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patients. , 1993, The Journal of urology.

[4]  S. Cha,et al.  Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  A. V. von Eschenbach,et al.  Prostate‐specific antigen. An important marker for prostate cancer treated by external beam radiation therapy , 1993, Cancer.

[6]  G. Hanks.  External beam radiation treatment for prostate cancer: still the gold standard. , 1992, Oncology.

[7]  A S Lichter,et al.  Three-dimensional conformal radiation therapy: a testable hypothesis. , 1991, International journal of radiation oncology, biology, physics.

[8]  A. V. von Eschenbach,et al.  The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate. , 1988, International journal of radiation oncology, biology, physics.

[9]  S. Leibel,et al.  Patterns of care outcome studies: results of the national practice in adenocarcinoma of the prostate. , 1984, International journal of radiation oncology, biology, physics.

[10]  S. C. Prasad,et al.  Computed tomography in definitive radiotherapy of prostatic carcinoma, part 2: definition of target volume. , 1980, International journal of radiation oncology, biology, physics.

[11]  S. Kramer,et al.  The study of the patterns of cancer care in radiation therapy , 1977, Cancer.

[12]  T E Schultheiss,et al.  Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer. , 1995, International journal of radiation oncology, biology, physics.

[13]  A. Hanlon,et al.  Patterns of Care and RTOG studies in prostate cancer: long-term survival, hazard rate observations, and possibilities of cure. , 1994, International journal of radiation oncology, biology, physics.

[14]  Hanks Ge.  Treatment of early stage prostate cancer: radiotherapy. , 1994 .

[15]  G E Hanks,et al.  Recent patterns of growth in radiation therapy facilities in the United States: a patterns of care study report. , 1992, International journal of radiation oncology, biology, physics.

[16]  H. Sandler,et al.  Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  G E Hanks,et al.  Conformal static field therapy for low volume low grade prostate cancer with rigid immobilization. , 1991, International journal of radiation oncology, biology, physics.

[18]  G E Hanks,et al.  Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate. , 1985, International journal of radiation oncology, biology, physics.